Statement Regarding Privacy Policy

New Stories

• Emyria prepares to open its first Sydney mental health clinic

  September 8, 2026 - - Latest News

• OncoSil Medical wins major investor backing to take its cancer device global

  September 7, 2026 - - Latest News

• Arovella Therapeutics moves 'off-the-shelf' cell therapy from lab to patients

  September 7, 2026 - - Latest News

• Neurizon Therapeutics appoints Chris Bremer as chief executive to steer ALS drug through final trial stage

  September 7, 2026 - - Latest News

• Australian biotech Immuron takes gut health treatment to the US market

  September 7, 2026 - - Latest News

• Prescient reaches key PTX-100 trial checkpoint ahead of December review

  September 3, 2026 - - Latest News

• ENA Respiratory secures funding to test antiviral nasal spray in people with asthma

  September 3, 2026 - - Latest News